Stazonex 1mg/tab 100 Tabletten by Knoll Pharmaceuticals

Usage

1. Identify your cycle type — oral-only or injectable — before opening your Stazonex pack, as start timing differs fundamentally between the two.
2. For oral-only cycles: count forward 24–48 hours from your last oral androgen tablet, then begin Stazonex 1 mg daily at that point.
3. For injectable cycles: calculate four to five half-lives of the longest ester used; do not start Stazonex until that washout window has elapsed — typically 10–21 days post-injection.
4. Use a clean tablet cutter if your protocol calls for 0.5 mg; the tablet's uniform formulation (confirmed by HPLC) supports reliable splitting.
5. Take each Stazonex tablet with water and a small meal to support consistent gastrointestinal absorption across the protocol duration.
6. Schedule a serum estradiol check at the midpoint of your PCT to confirm CYP19A1 inhibition is within target range and adjust dose if estradiol is out of band — avoid dose escalation without laboratory evidence.

Warnings

Frequently asked questions

When should you start anastrozole PCT after an oral-only steroid cycle?

After an oral-only cycle, anastrozole PCT can begin within 24 to 48 hours of the final oral dose. Oral androgens carry half-lives measured in hours rather than days, so systemic androgen levels fall rapidly. Starting Stazonex promptly capitalises on this fast washout, providing aromatase inhibition at the moment HPG axis recovery begins — without the waiting period injectable cycles demand.

Why do you have to wait longer to start PCT after a long-ester injectable cycle?

Long-ester injectables such as enanthate or decanoate continue releasing active androgen through ester hydrolysis for 10 to 21 days after the final injection. Starting anastrozole while androgen levels remain elevated from ester release adds little benefit and wastes your protocol window. Waiting for sufficient hydrolysis — typically one to three weeks depending on the ester — before introducing Stazonex ensures aromatase inhibition is applied when the HPG axis is actually in recovery mode.

How does the half-life of the last compound I used affect my PCT start date?

The half-life of your final compound is the primary determinant of PCT start timing. A compound with a 6-hour half-life clears to sub-suppressive levels within two to three days; one with a 10-day half-life may still suppress the axis two to three weeks post-injection. Mapping your PCT start to roughly four to five half-lives of the last compound ensures Stazonex is introduced during genuine androgen decline rather than during ongoing ester-mediated release.

Can Stazonex tablets be split for lower-dose protocols on an oral-only PCT?

Yes. Stazonex 1 mg tablets are scored to support splitting, allowing practitioners to administer 0.5 mg doses where lighter aromatase inhibition is appropriate — common in short oral-cycle PCT where aggressive estrogen suppression is unnecessary. Splitting should be done with a clean tablet cutter to maintain dose accuracy; HPLC batch documentation confirms that active ingredient is uniformly distributed across the tablet, supporting reliable split-dose delivery.

How are Stazonex tablets packaged, and does packaging affect shelf stability during a longer injectable-cycle PCT?

Stazonex is supplied in a sealed 100-tablet format designed to maintain tablet integrity throughout extended protocols. For injectable-cycle PCTs that may run 8 to 12 weeks, keeping the unused portion in its original, moisture-protected container and storing it away from heat and light preserves active-ingredient stability. The sealed format ensures tablets not yet in use remain protected while the user works through the earlier weeks of a prolonged PCT schedule. (2) angle_used

Manufacturer

Knoll Pharmaceuticals' approach to Stazonex distribution centres on supply-chain integrity from the point of API release through to the moment the sealed tablet pack reaches the end user. Finished Stazonex batches leave the facility accompanied by per-lot HPLC content assay records confirming anastrozole potency at the 1 mg/tablet specification, alongside LAL endotoxin screening results from the API acceptance stage — documentation that travels with the batch identity through the logistics chain. Order fulfilment is structured around discrete, tamper-evident packaging that protects tablet integrity across varying transit conditions, a practical consideration for customers in US and UK markets where delivery timelines and ambient conditions differ. Customers requiring batch-specific quality records for Stazonex can request documentation directly through Knoll's support channel, receiving traceable evidence linking their specific pack to its production lot rather than a generalised quality statement.